GASTROINTESTINAL HYPOMOTILITY

This adverse event was reported 2256 times

These drugs are most commonly taken by patients reporting GASTROINTESTINAL HYPOMOTILITY:

# Drug Count
0 DULAGLUTIDE 553
1 ORAL SEMAGLUTIDE 511
2 METFORMIN 404
3 METFORMIN ER 500 MG 398
4 METFORMIN ER 750 MG 398
5 TIRZEPATIDE 387
6 CLOZAPINE 211
7 INSULIN GLARGINE 198
8 GABAPENTIN 195
9 OMEPRAZOLE MAGNESIUM 189
See all common drugs associated with GASTROINTESTINAL HYPOMOTILITY

GASTROINTESTINAL HYPOMOTILITY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BRYONIA (ALBA), CARDUUS MARIANUS, CHELIDONIUM MAJUS, HEPAR SUIS, TARAXACUM OFFICINALE 1 0.0769
1 BISMUTH SUBGALLATE 1 0.0217
2 CHLOROTHIAZIDE SODIUM 7 0.0076
3 ORAL SEMAGLUTIDE 511 0.0065
4 CHLOROTHIAZIDE 8 0.0063
5 DULAGLUTIDE 553 0.0062
6 PSYLLIUM HUSK 7 0.0052
7 PRUCALOPRIDE 11 0.0046
8 PLECANATIDE 9 0.0043
9 CHLORPHENIRAMINE MALEATE, PSEUDOEPHEDRINE HCL 1 0.0040
See all drugs enriched for association with GASTROINTESTINAL HYPOMOTILITY

GASTROINTESTINAL HYPOMOTILITY is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Serotonin-4 Receptor Agonist [EPC] 3 0.0046
1 Guanylate Cyclase-C Agonist [EPC] 9 0.0043
2 Bismuth [EPC] 14 0.0025
3 Sclerosing Agent [EPC] 1 0.0022
4 Tricyclic Antidepressant [EPC] 1 0.0021
5 GLP-1 Receptor Agonist [EPC] 851 0.0019
6 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 196 0.0018
7 Chloride Channel Activator [EPC] 13 0.0014
8 Sulfonylurea [EPC] 166 0.0013
9 Human Blood Coagulation Factor [EPC] 1 0.0012
See all drug classes enriched for association with GASTROINTESTINAL HYPOMOTILITY